Evidence map›Paper›PMID 28127543›Full record

ReviewJournal of diabetes and metabolic disorders2017

National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic.

Niloofar Peykari, Hassan Hashemi, Rasoul Dinarvand, Mohammad Haji-Aghajani, Reza Malekzadeh, Ali Sadrolsadat, Ali Akbar Sayyari, Mohsen Asadi-Lari, Alireza Delavari, Farshad Farzadfar and 7 more

Abstract readReview
In one paragraph

Review in Journal of diabetes and metabolic disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Niloofar PeykariIranian Non Communicable Diseases Committee (INCDC), Ministry of Health and Medical Education, Tehran, Iran.
Hassan HashemiINCDC, Ministry of Health and Medical Education, Tehran, Iran.
Rasoul DinarvandFood and Drug Organization, INCDC, Ministry of Health and Medical Education, Tehran, Iran.
Mohammad Haji-AghajaniDeputy of Curative Affairs , INCDC, Ministry of Health and Medical Education, Tehran, Iran.
Reza MalekzadehDeputy of Research and Technology, INCDC, Ministry of Health and Medical Education, Tehran, Iran.
Ali SadrolsadatDeputy of Development, Management, and Resources, INCDC, Ministry of Health and Medical Education, Tehran, Iran.
Ali Akbar SayyariDeputy of Public Health, INCDC, Ministry of Health and Medical Education, Tehran, Iran.
Mohsen Asadi-LariInternational Affairs, INCDC, Ministry of Health and Medical Education, Tehran, Iran.
Alireza DelavariDigestive Disease Research Center, Tehran University of Medical Sciences, and INCDC, MOHME, Tehran, Iran.
Farshad FarzadfarNon-Communicable Diseases Research Center, EMRI, Tehran University of Medical Sciences, Tehran, Iran.
Aliakbar HaghdoostKerman University of Medical Sciences, Kerman, Iran.
Ramin HeshmatChronic Diseases Research Center, EMRI, Tehran University of Medical Sciences, Tehran, Iran.
Hamidreza JamshidiShahid Beheshti University of Medical Sciences, Tehran, Iran.
Naser KalantariShahid Beheshti University of Medical Sciences, Tehran, Iran.
Ahmad KooshaTabriz University of Medical Sciences, Tabriz, Iran.
Amirhossein TakianTehran University of Medical Sciences, Tehran, Iran.
Bagher LarijaniINCDC, Ministry of Health and Medical Education, and EMRI, TUMS, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging Non-communicable diseases burden move United Nation to call for 25% reduction by 2025 in premature mortality from non-communicable diseases (NCDs). The World Health Organization (WHO) developed global action plan for prevention and control NCDs, but the countries' contexts, priorities, and health care system might be different. Therefore, WHO expects from countries to meet national commitments to achieve the 25 by 25 goal through adapted targets and action plan. In this regards, sustainable high-level political statement plays a key role in rules and regulation support, and multi-sectoral collaborations to NCDs' prevention and control by considering the sustainable development goals and universal health coverage factors. Therefore, Iran established the national authority's structure as Iranian Non Communicable Diseases Committee (INCDC) and developed NCDs' national action plan through multi-sectoral approach and collaboration researchers and policy makers. Translation Iran's expertise could be benefit to mobilizing leadership in other countries for practical action to save the millions of peoples.

Indexed as

Action planIranNon-communicable diseases

Identifiers

PMID28127543
PMCPMC5260033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.